CD66b - CD64 dim CD115 - cells in the human bone marrow represent neutrophil-committed progenitors

• Published in: Nature immunology Vol. 23; no. 5; p. 679
• Main Authors: Calzetti, Federica, Finotti, Giulia, Tamassia, Nicola, Bianchetto-Aguilera, Francisco, Castellucci, Monica, Canè, Stefania, Lonardi, Silvia, Cavallini, Chiara, Matte, Alessandro, Gasperini, Sara, Signoretto, Ilaria, Benedetti, Fabio, Bonifacio, Massimiliano, Vermi, William, Ugel, Stefano, Bronte, Vincenzo, Tecchio, Cristina, Scapini, Patrizia, Cassatella, Marco A
• Format: Journal Article
• Language: English
• Published: United States 01.05.2022
• Subjects: Bone Marrow; Bone Marrow Cells; Cell Differentiation; COVID-19; Humans; Interferons; Neutrophils; Receptor Protein-Tyrosine Kinases; Receptors, IgG
• ISSN: 1529-2916

Here we report the identification of human CD66b CD64 CD115 neutrophil-committed progenitor cells (NCPs) within the SSC CD45 CD34 and CD34 subsets in the bone marrow. NCPs were either CD45RA or CD45RA , and in vitro experiments showed that CD45RA acquisition was not mandatory for their maturation process. NCPs exclusively generated human CD66b neutrophils in both in vitro differentiation and in vivo adoptive transfer experiments. Single-cell RNA-sequencing analysis indicated NCPs fell into four clusters, characterized by different maturation stages and distributed along two differentiation routes. One of the clusters was characterized by an interferon-stimulated gene signature, consistent with the reported expansion of peripheral mature neutrophil subsets that express interferon-stimulated genes in diseased individuals. Finally, comparison of transcriptomic and phenotypic profiles indicated NCPs represented earlier neutrophil precursors than the previously described early neutrophil progenitors (eNePs), proNeus and COVID-19 proNeus. Altogether, our data shed light on the very early phases of neutrophil ontogeny.